Delivery Order SPE2DB22D1017-SPE2DB25FG8KM
Award Date 7/29/25
Potential Completion Date 8/19/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,466.57 firm fixed price delivery order contract to supply Zeposia 0.92 mg capsules. This order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $4,620.93, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award reflects AmerisourceBergen's capability to deliver pharmaceutical products to support federal medical procurement needs. The contract is executed out of the vendor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Zeposia 0.92 mg capsules. The $4,466.57 order has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 20, 2025, and represents a non-competitive set-aside delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed and delivered from the company's Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) for ZEPOSIA 0.92 mg capsules (30-count units) valued at $13,862.79. The award was made on July 28, 2025, under a Firm Fixed Price contract type with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a continuation of the company's extensive pharmaceutical...
- This delivery order, valued at $9,241.86, awards AmerisourceBergen Drug Corp the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed price contract. The award was made competitively without set-aside designation and is set for completion by August 19, 2025. The Defense Logistics Agency, which handles medical supply chain procurement for the Department of Defense, is the funding federal agency, with performance taking place at AmerisourceBergen's corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 MG capsules. The order, valued at $13,399.71, has a firm fixed price and a completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering this medication to support various government healthcare programs and facilities, including military treatment facilities and veterans' hospitals. The contract is not set aside for any...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count) on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,399.71 Firm Fixed Price Delivery Order is for the supply of Zeposia 0.92 mg capsules, with a completion date of June 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for the...